Equities research analysts at Ladenburg Thalmann Financial Services began coverage on shares of SeaSpine (NASDAQ:SPNE) in a report issued on Thursday, Marketbeat reports. The brokerage set a “buy” rating and a $20.00 price target on the medical equipment provider’s stock. Ladenburg Thalmann Financial Services’ target price would indicate a potential upside of 99.80% from the stock’s current price.
Other equities research analysts have also issued reports about the stock. HC Wainwright restated a “buy” rating and issued a $15.00 price objective on shares of SeaSpine in a report on Friday, November 3rd. BTIG Research restated a “buy” rating on shares of SeaSpine in a report on Monday, November 6th. Piper Jaffray Companies restated a “buy” rating and issued a $22.00 price objective on shares of SeaSpine in a report on Sunday, August 20th. Finally, Zacks Investment Research upgraded shares of SeaSpine from a “hold” rating to a “buy” rating and set a $13.00 price objective for the company in a report on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. SeaSpine presently has a consensus rating of “Buy” and a consensus target price of $17.25.
SeaSpine (NASDAQ:SPNE) traded up $0.05 during mid-day trading on Thursday, reaching $10.01. 46,260 shares of the company’s stock were exchanged, compared to its average volume of 56,472. SeaSpine has a fifty-two week low of $6.31 and a fifty-two week high of $13.46.
COPYRIGHT VIOLATION WARNING: This piece was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/14/seaspine-spne-receives-new-coverage-from-analysts-at-ladenburg-thalmann-financial-services.html.
SeaSpine Company Profile
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.
Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.